Wednesday, September 24, 2025 3:37:58 PM
It is unclear exactly what "Advent" will be when bought back. It clearly includes the physical assets at Sawston. I am fairly sure it does not include the people as that would be illegal even in the UK.
But what about that other facility, contracts and cash?
Even if NWBO gets it all, LP pocketed over $10M by letting NWBO build her CDMO so she could sell it back. What we do not know is what she might have split off of Advent prior to the deal. So could well have picked up more like $20M.
Also, the UK bio meltdown might make CDMOs less valuable. By a lot. So maybe cash out for chump change?
This mess went from awful to just a modestly bad deal for NWBO. So that is a huge win. But nothing to bless LP for as some longs are doing.
But what about that other facility, contracts and cash?
Even if NWBO gets it all, LP pocketed over $10M by letting NWBO build her CDMO so she could sell it back. What we do not know is what she might have split off of Advent prior to the deal. So could well have picked up more like $20M.
Also, the UK bio meltdown might make CDMOs less valuable. By a lot. So maybe cash out for chump change?
This mess went from awful to just a modestly bad deal for NWBO. So that is a huge win. But nothing to bless LP for as some longs are doing.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
